enGene Inc (ENGNW)
enGene to Participate in Upcoming Investor Conferences
enGene to Participate in Upcoming Investor Conferences
MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
Baxter International, Inc. DEADLINE ALERT: Baxter International, Inc. Investors Urged to Contact Kirby McInerney LLP About Class Action Lawsuit
enGene to Participate in Upcoming Investor Conferences
4 (Statement of Changes in Beneficial Ownership) SEC Filing
Perimeter Solutions to Present at Baird Global Industrial Conference
Johnson & Johnson - DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year